Article
Mechanisms and spread of fluoroquinolone resistance in Streptococcus pneumoniae.
Research in microbiology - 1 Jan 2000
Varon E, Gutmann L
Abstract excerpt
The development of fluoroquinolones (FQs) with enhanced activity against Streptococcus pneumoniae is a potential advance in the treatment of pneumococcal infections, particularly those due to beta-lactam-resistant pneumococci. However, FQ-resistant clinical isolates selected by the older FQs have already been reported, with mutation(s) in both FQ targets conferring cross-resistance to newer FQs. It is likely that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
